SCHEMBL4516479

SCHEMBL4516479

COCC12CN(S(=O)(=O)c3cc4cc(Cl)ccc4n3S(=O)(=O)c3ccccc3)CC(=O)N1CC1(CCN(Cc3ccccc3)CC1)O2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.39
TSHR P16473 3/20 0.36
LMNA P02545 3/20 0.36
MAPK1 P28482 1/20 0.36
TRPV4 Q9HBA0 1/20 0.36
CYP2D6 P10635 3/20 0.36
USP2 O75604 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
PPARG P37231 3/20 0.35
PPARA Q07869 3/20 0.35
PPARD Q03181 2/20 0.35
GAA P10253 2/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4522978 0.91 PPARG (0.37) PPARGPPARAPPARDHTR6
SCHEMBL4528222 0.91 PPARG (0.37) PPARGPPARAPPARDHTR6
SCHEMBL4534420 0.90 ALDH1A1 (0.39) ALDH1A1KDM4ETSHRLMNAMAPK1
SCHEMBL6078359 0.88 ALDH1A1 (0.42) ALDH1A1KDM4ETSHRLMNAMAPK1
SCHEMBL4535048 0.85 PPARG (0.37) PPARGPPARAPPARDHTR6
SCHEMBL4527719 0.84 PPARG (0.34) ALDH1A1KDM4ELMNATRPV4CYP2D6
SCHEMBL4514925 0.83 PPARG (0.39) ALDH1A1CYP2D6PPARGPPARAPPARD
SCHEMBL4534417 0.83 F10 (0.45) ALDH1A1KDM4ETSHRLMNAMAPK1
SCHEMBL4522105 0.83 F10 (0.46) ALDH1A1KDM4ETSHRLMNAMAPK1
SCHEMBL4529442 0.82 KDM4E (0.34) ALDH1A1KDM4ETSHRTRPV4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090076015-A1 Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2009-03-19 US disclosed
EP-1864984-A1 TRICYCLIC SPIRO COMPOUND COMPRISING ACYL GROUP BOUND TO NITROGEN ATOM IN THE RING MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2007-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076015-A1 Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring KCNH1, SCN1A, SCN10A ALDH1A1 2791/4885KDM4E 2297/4885TSHR 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.